T. Rowe Price Active Crypto ETF files a Free Writing Prospectus, detailing its multi-token approach to crypto assets and emphasizing active management.
| Name | T. Rowe Price Active Crypto ETF |
|---|---|
| CIK | 0002089855 |
| Tickers | TKNZ |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 6221 Commodity Contracts Brokers & Dealers |
| EIN | 394422405 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 410-345-2000 |
| Website | — |
| Investor website | — |
| Owner org | 09 Crypto Assets |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
T. Rowe Price Active Crypto ETF files a Free Writing Prospectus, detailing its multi-token approach to crypto assets and emphasizing active management.
T. Rowe Price Active Crypto ETF files a prospectus supplement including its quarterly report, highlighting transparency in the crypto sector.
T. Rowe Price Active Crypto ETF has filed its quarterly report for Q3 2026, showcasing its performance and commitment to the crypto investment sector.
T. Rowe Price Active Crypto ETF updates its strategy in a new filing, emphasizing active management and diverse token exposure in the cryptocurrency market.
T. Rowe Price Active Crypto ETF updates its prospectus to expand eligible crypto assets, reflecting growing interest in the cryptocurrency market.
T. Rowe Price Active Crypto ETF updates focus on crypto assets, signaling commitment to on-chain finance in a rapidly evolving market.
T. Rowe Price Active Crypto ETF sees AUM grow to $34.9B, launching six new ETFs, signaling strong momentum in the cryptocurrency investment sector.
T. Rowe Price Active Crypto ETF's recent filing signals a commitment to the crypto market, impacting the commodity contracts brokers and dealers sector.
70 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-025820 | 333-291007 | 261575767 | 34 | 254337 | |||
| 2026-11-12 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-025128 | 333-291007 | 261542678 | 34 | 219966 | |||
| 2026-11-10 | 424B3 | 424B3 | 0001193125-26-455398 | 333-291007 | 261540175 | 33 | 672603 | |||
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-454710 | 001-43363 | 261538724 | 34 | 2565231 | 1 | 1 | |
| 2026-11-05 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-024526 | 333-291007 | 261525150 | 34 | 41675 | |||
| 2026-11-04 | 424B3 | PROSPECTUS SUPPLEMENT | 0001999371-26-024444 | 333-291007 | 261521041 | 33 | 70252 | |||
| 2026-11-04 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-024441 | 333-291007 | 261520972 | 34 | 8478 | |||
| 2026-10-28 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-023675 | 333-291007 | 261492596 | 34 | 51309 | |||
| 2026-10-22 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-023266 | 333-291007 | 261477470 | 34 | 1235373 | |||
| 2026-10-15 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-022857 | 333-291007 | 261463527 | 34 | 51256361 | |||
| 2026-10-08 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-022480 | 333-291007 | 261450120 | 34 | 841177 | |||
| 2026-10-08 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-022414 | 333-291007 | 261448468 | 34 | 1269345 | |||
| 2026-10-02 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-021930 | 333-291007 | 261434076 | 34 | 1212608 | |||
| 2026-09-25 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-021325 | 333-291007 | 261406555 | 34 | 7929 | |||
| 2026-09-16 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-020648 | 333-291007 | 261384046 | 34 | 3660206 | |||
| 2026-09-15 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-020547 | 333-291007 | 261380186 | 34 | 95628 | |||
| 2026-09-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-020331 | 333-291007 | 261371931 | 34 | 289252 | |||
| 2026-09-09 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-020196 | 333-291007 | 261367453 | 34 | 397264 | |||
| 2026-09-09 | 424B3 | PROSPECTUS SUPPLEMENT | 0001999371-26-020168 | 333-291007 | 261366719 | 33 | 65071 | |||
| 2026-09-02 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-019634 | 333-291007 | 261355852 | 34 | 20794 | |||
| 2026-08-31 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-019324 | 333-291007 | 261345169 | 34 | 35289 | |||
| 2026-08-12 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-017705 | 333-291007 | 261267460 | 34 | 137644 | |||
| 2026-08-11 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-017617 | 333-291007 | 261262337 | 34 | 11428023 | |||
| 2026-08-11 | 424B3 | 424B3 | 0001193125-26-342793 | 333-291007 | 261259858 | 33 | 286719 | |||
| 2026-08-10 | 10-Q | 10-Q | 0001193125-26-341871 | 001-43363 | 261257452 | 34 | 1484580 | 1 | 1 | |
| 2026-08-04 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016892 | 333-291007 | 261235934 | 34 | 13660541 | |||
| 2026-08-04 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016877 | 333-291007 | 261235422 | 34 | 6072 | |||
| 2026-08-03 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016793 | 333-291007 | 261231506 | 34 | 3327590 | |||
| 2026-08-03 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016748 | 333-291007 | 261230648 | 34 | 10983 | |||
| 2026-07-31 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016565 | 333-291007 | 261225604 | 34 | 13599 | |||
| 2026-07-30 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016515 | 333-291007 | 261224085 | 34 | 9168 | |||
| 2026-07-30 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016488 | 333-291007 | 261222695 | 34 | 34059 | |||
| 2026-07-30 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016427 | 333-291007 | 261221700 | 34 | 863806 | |||
| 2026-07-30 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016406 | 333-291007 | 261220544 | 34 | 8030 | |||
| 2026-07-29 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016304 | 333-291007 | 261214191 | 34 | 482560 | |||
| 2026-07-27 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-016064 | 333-291007 | 261206477 | 34 | 9113518 | |||
| 2026-07-23 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015688 | 333-291007 | 261196807 | 34 | 8294 | |||
| 2026-07-22 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015579 | 333-291007 | 261193819 | 34 | 16976 | |||
| 2026-07-22 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015576 | 333-291007 | 261193647 | 34 | 88345 | |||
| 2026-07-22 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015542 | 333-291007 | 261192767 | 34 | 7293617 | |||
| 2026-07-20 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015403 | 333-291007 | 261186435 | 34 | 97634 | |||
| 2026-07-17 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015287 | 333-291007 | 261182533 | 34 | 65153 | |||
| 2026-07-16 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015128 | 333-291007 | 261178906 | 34 | 1320196 | |||
| 2026-07-16 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015126 | 333-291007 | 261178891 | 34 | 1068462 | |||
| 2026-07-15 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-015091 | 333-291007 | 261178005 | 34 | 31241 | |||
| 2026-07-15 | 424B3 | PROSPECTUS SUPPLEMENT | 0001999371-26-014984 | 333-291007 | 261175196 | 33 | 28484 | |||
| 2026-07-15 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001999371-26-014983 | 001-43363 | 261175193 | 34 | 376709 | 1 | 1 |
| 2026-07-14 | 424B3 | PROSPECTUS SUPPLEMENT | 0001999371-26-014982 | 333-291007 | 261175190 | 33 | 83388 | |||
| 2026-07-14 | CERT | NYSE ARCA CERTIFICATION | 0001143362-26-000255 | 001-43363 | 261175034 | 34 | 385539 | |||
| 2026-07-13 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014794 | 333-291007 | 261170414 | 34 | 391197 | |||
| 2026-07-13 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014792 | 333-291007 | 261170407 | 34 | 748680 | |||
| 2026-07-13 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014788 | 333-291007 | 261170353 | 34 | 1537830 | |||
| 2026-07-13 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014786 | 333-291007 | 261170333 | 34 | 1113442 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014723 | 333-291007 | 261168015 | 34 | 12315 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014704 | 333-291007 | 261167388 | 34 | 2739101 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014703 | 333-291007 | 261167385 | 34 | 124946 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014702 | 333-291007 | 261167370 | 34 | 82159 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014701 | 333-291007 | 261167358 | 34 | 692589 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014700 | 333-291007 | 261167351 | 34 | 971739 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014698 | 333-291007 | 261167346 | 34 | 1536429 | |||
| 2026-07-10 | FWP | FREE WRITING PROSPECTUS | 0001999371-26-014697 | 333-291007 | 261167318 | 34 | 867486 | |||
| 2026-06-23 | 424B3 | PROSPECTUS | 0001999371-26-013250 | 333-291007 | 261109580 | 33 | 1148918 | |||
| 2026-06-22 | 8-A12B | REGISTRATION/LISTING OF A CLASS OF SECURITIES | 0001999371-26-013156 | 001-43363 | 261104911 | 34 | 13530 | |||
| 2026-06-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002059 | 333-291007 | 261104717 | 33 | 1695 | ||
| 2026-06-16 | S-1/A | AMENDMENT TO FORM S-1 | 0001999371-26-012919 | 333-291007 | 261094382 | 33 | 71100 | |||
| 2026-05-15 | S-1/A | AMENDMENT TO FORM S-1 | 0001999371-26-010860 | 333-291007 | 26985820 | 33 | 956471 | |||
| 2026-04-27 | S-1/A | AMENDMENT TO FORM S-1 | 0001999371-26-009120 | 333-291007 | 26898023 | 33 | 2448875 | |||
| 2026-03-16 | S-1/A | AMENDMENT TO FORM S-1 | 0001999371-26-005896 | 333-291007 | 26754994 | 33 | 917031 | |||
| 2026-02-11 | S-1/A | AMENDMENT TO FORM S-1 | 0001999371-26-003054 | 333-291007 | 26620295 | 33 | 896101 | |||
| 2025-10-22 | S-1 | FORM S-1 | 0001999371-25-015832 | 333-291007 | 251409138 | 33 | 1181758 | 1 | 1 |
One latest value per concept from companyfacts (56 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 800,000 | 2026-11-02 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | Assets | Assets | USD | 25.43M | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | AssetsNet | Net Assets | USD | 25.42M | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | Cash | Cash | USD | 5,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 5,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 5,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 760,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 760,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | GrossInvestmentIncomeOperating | Gross Investment Income, Operating | USD | 1,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | IncreaseDecreaseInManagementFeePayable | IncreaseDecreaseInManagementFeePayable | USD | 14,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement | InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement | USD | 30,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyExpenseRatioExcludingIncentiveFee | Investment Company, Expense Ratio Excluding Incentive Fee | pure | 0.009 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyExpenseRatioIncludingIncentiveFee | Investment Company, Expense Ratio Including Incentive Fee | pure | 0.008 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyGainLossOnInvestmentPerShare | Investment Company, Gain (Loss) on Investment, Per Share | USD/shares | 8.49 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyIncreaseDecreaseFromShareTransaction | InvestmentCompanyIncreaseDecreaseFromShareTransaction | USD | 19.53M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyInvestmentIncomeLossPerShare | Investment Company, Investment Income (Loss), Per Share | USD/shares | -0.04 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyInvestmentIncomeLossRatio | Investment Company, Investment Income (Loss) Ratio | pure | -0.007 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyManagementFeeWaived | InvestmentCompanyManagementFeeWaived | USD | 6,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease | Investment Company, Net Asset Value Per Share, Period Increase (Decrease) | USD/shares | 8.45 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentCompanyTotalReturn | Investment Company, Total Return | pure | 0.338 | 2026-07-16 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentIncomeInvestmentExpense | Investment Income, Investment Expense | USD | 36,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 0 | 2026-04-01 | 2026-06-30 | 2026 | Q1 | 10-Q | 2026-08-10 | 0001193125-26-341871 |
| us-gaap | InvestmentOwnedAtCost | Investment Owned, at Cost | USD | 19.72M | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | InvestmentOwnedAtFairValue | Investment Owned, at Fair Value | USD | 25.43M | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | InvestmentOwnedPercentOfNetAssets | Investment Owned, Percent of Net Assets | pure | 1 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | Investments | Investments | USD | 0 | 2026-06-30 | 2026 | Q1 | 10-Q | 2026-08-10 | 0001193125-26-341871 | |
| us-gaap | Liabilities | Liabilities | USD | 14,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | ManagementFeeExpense | Management Fee Expense | USD | 36,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | ManagementFeePayable | Management Fee Payable | USD | 14,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | NetAssetValuePerShare | Net Asset Value Per Share | USD/shares | 33.45 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 19.53M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -19.52M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 5.89M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | NetInvestmentIncome | Net Investment Income | USD | -29,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | NonInvestmentAssetsLessNonInvestmentLiabilities | Non Investment Assets Less Non Investment Liabilities | USD | -9,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets | Non Investment Assets Less Non Investment Liabilities, Percent of Net Assets | pure | -0 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | PaymentsForPurchaseOfInvestmentOperatingActivity | PaymentsForPurchaseOfInvestmentOperatingActivity | USD | 23.68M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | ProceedsFromDispositionOfInvestmentOperatingActivity | ProceedsFromDispositionOfInvestmentOperatingActivity | USD | 4.17M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 19.53M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 14.98M | 2026-07-14 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | USD | 5.92M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | USD | 209,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 0 | 2026-04-01 | 2026-06-30 | 2026 | Q1 | 10-Q | 2026-08-10 | 0001193125-26-341871 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 25 | 2026-07-14 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 760,000 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 | |
| us-gaap | StockholdersEquityPeriodIncreaseDecrease | Stockholders' Equity, Period Increase (Decrease) | USD | 25.42M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 760,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | StockIssuedDuringPeriodSharesPeriodIncreaseDecrease | Stock Issued During Period, Shares, Period Increase (Decrease) | shares | 760,000 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 19.53M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 0 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 0 | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax | USD | 5.71M | 2026-04-01 | 2026-09-30 | 2026 | Q2 | 10-Q | 2026-11-10 | 0001193125-26-454710 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 0 | 2026-04-01 | 2026-06-30 | 2026 | Q1 | 10-Q | 2026-08-10 | 0001193125-26-341871 |